4.7 Article

Protective effects of imipramine in murine endotoxin-induced acute lung injury

Journal

EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 638, Issue 1-3, Pages 128-133

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejphar.2010.04.005

Keywords

Acute lung injury; Imipramine; Lipopolysaccharide; Nuclear factor-kappa B

Funding

  1. State Natural Sciences Foundation [30770930]
  2. Program of Shanghai Subject Chief Scientist [07XD14012]

Ask authors/readers for more resources

The tricyclic antidepressant imipramine has recently emerged as a cytoprotective agent, exerting beneficial effects in inflammatory tissue injury. The present study aimed to investigate therapeutic effects of imipramine in murine model of endotoxin-induced acute lung injury. Mice were administrated intraperitoneally with LPS (lipopolysaccharide) from Escherichia coli or vehicle. Imipramine was administrated intraperitoneally 30 min before LPS challenge. Pretreatment of mice with imipramine reduced lethality. Impramine also significantly attenuated lung inflammation, lung edema, MPO (myeloperoxidase) activity, lung tissue pathological changes and nuclear factor-kappa B DNA binding activity. The results of this study suggest that imipramine can exert protective effects in endotoxin-induced acute lung injury by suppressing nuclear factor-kappa B-mediated expression of inflammatory genes. Thus, imipramine could be a potential novel therapeutic agent for the treatment for acute lung injury. (C) 2010 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available